AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes

ConditionsCongenital Anomalies Neonatal Complications Perinatal Outcomes Perinatal Outcomes of the Mother and Fetus

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-1

SponsorFetalFirst Limited

About this trial

This study aims to develop advanced artificial intelligence (AI) models that predict neonatal risks and complications based on historical multimodal health data, including ultrasound and MRI scans. The objective is to empower clinicians and provide clear, compassionate support for families navigating complex prenatal diagnoses.

Eligibility criteria

Qualifiers

Historical, de-identified neonatal records including ultrasound images, MRI scans, and clinical documentation available for analysis.

Disqualifiers

Cases with incomplete or missing critical data elements required for AI model analysis.

Trial design

Treatments tested in this trial

Not listed

Trial groups

50,000 Participants

are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators

FetalFirst Limited

Lead sponsor

Source ClinicalTrials.gov